121 Summary and general discussion 49. Hariton E, Locascio JJ. Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials. Bjog. 2018;125(13):1716. 50. McDonald S, Nikles J. N-of-1 Trials in Healthcare. Healthcare (Basel). 2021;9(3). 51. Janssen Daalen JM, Meinders MJ, Giardina F, et al. Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol. BMC Neurol. 2022;22(1):262. 52. Mendonça M, Cotovio G, Barbosa R, Grunho M, Oliveira-Maia AJ. An Argument in Favor of Deep Brain Stimulation for Uncommon Movement Disorders: The Case for N-of-1 Trials in Holmes Tremor. Front Hum Neurosci. 2022;16:921523. 53. Shribman S, Reid E, Crosby AH, Houlden H, Warner TT. Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches. Lancet Neurol. 2019;18(12):11361146. 7
RkJQdWJsaXNoZXIy MjY0ODMw